Annual long term liabilities:
$74.65M-$573.43M(-88.48%)Summary
- As of today (September 12, 2025), AMPH annual total long term liabilities is $74.65 million, with the most recent change of -$573.43 million (-88.48%) on December 31, 2024.
- During the last 3 years, AMPH annual long term liabilities has risen by +$51.93 million (+228.59%).
- AMPH annual long term liabilities is now -88.48% below its all-time high of $648.08 million, reached on December 31, 2023.
Performance
AMPH Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$681.44M+$5.50M(+0.81%)Summary
- As of today (September 12, 2025), AMPH quarterly total long term liabilities is $681.44 million, with the most recent change of +$5.50 million (+0.81%) on June 30, 2025.
- Over the past year, AMPH quarterly long term liabilities has increased by +$40.24 million (+6.28%).
- AMPH quarterly long term liabilities is now at all-time high.
Performance
AMPH quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AMPH Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.5% | +6.3% |
| 3 y3 years | +228.6% | +2965.8% |
| 5 y5 years | +443.9% | +4388.2% |
AMPH Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.5% | +240.3% | at high | +3150.7% |
| 5 y | 5-year | -88.5% | +443.9% | at high | +4388.2% |
| alltime | all time | -88.5% | >+9999.0% | at high | >+9999.0% |
AMPH Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $681.44M(+0.8%) |
| Mar 2025 | - | $675.94M(+805.5%) |
| Dec 2024 | $74.65M(-88.5%) | $74.65M(-88.7%) |
| Sep 2024 | - | $658.49M(+2.7%) |
| Jun 2024 | - | $641.21M(-0.9%) |
| Mar 2024 | - | $646.79M(-0.2%) |
| Dec 2023 | $648.08M(+2854.7%) | $648.08M(+2702.5%) |
| Sep 2023 | - | $23.13M(-7.7%) |
| Jun 2023 | - | $25.06M(+11.0%) |
| Mar 2023 | - | $22.58M(+2.9%) |
| Dec 2022 | $21.93M(-3.5%) | $21.93M(+4.6%) |
| Sep 2022 | - | $20.96M(-5.7%) |
| Jun 2022 | - | $22.23M(-1.3%) |
| Mar 2022 | - | $22.51M(-0.9%) |
| Dec 2021 | $22.72M(+21.7%) | $22.72M(+1.0%) |
| Sep 2021 | - | $22.49M(+18.7%) |
| Jun 2021 | - | $18.96M(+0.4%) |
| Mar 2021 | - | $18.88M(+1.2%) |
| Dec 2020 | $18.66M(+36.0%) | $18.66M(+19.6%) |
| Sep 2020 | - | $15.60M(+2.8%) |
| Jun 2020 | - | $15.18M(+5.1%) |
| Mar 2020 | - | $14.45M(+5.3%) |
| Dec 2019 | $13.72M | $13.72M(+32.4%) |
| Sep 2019 | - | $10.37M(-0.9%) |
| Jun 2019 | - | $10.47M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $10.35M(-0.4%) |
| Dec 2018 | $10.39M(+11.7%) | $10.39M(+2.4%) |
| Sep 2018 | - | $10.14M(+3.2%) |
| Jun 2018 | - | $9.84M(-5.7%) |
| Mar 2018 | - | $10.43M(+12.2%) |
| Dec 2017 | $9.30M(+68.8%) | $9.30M(+24.3%) |
| Sep 2017 | - | $7.48M(+8.8%) |
| Jun 2017 | - | $6.88M(+13.8%) |
| Mar 2017 | - | $6.04M(+9.7%) |
| Dec 2016 | $5.51M(-84.1%) | $5.51M(+2.3%) |
| Sep 2016 | - | $5.38M(-84.8%) |
| Jun 2016 | - | $35.45M(+5.8%) |
| Mar 2016 | - | $33.50M(-3.4%) |
| Dec 2015 | $34.67M(+293.6%) | $34.67M(+275.5%) |
| Sep 2015 | - | $9.23M(-2.4%) |
| Jun 2015 | - | $9.46M(+2.3%) |
| Mar 2015 | - | $9.24M(+4.9%) |
| Dec 2014 | $8.81M(-24.9%) | $8.81M(-35.5%) |
| Sep 2014 | - | $13.66M(+31.4%) |
| Jun 2014 | - | $10.39M(-6.7%) |
| Mar 2014 | - | $11.14M(-5.0%) |
| Dec 2013 | $11.73M(+46.4%) | $11.73M(+46.9%) |
| Sep 2013 | - | $7.99M(-0.3%) |
| Dec 2012 | $8.01M(>+9900.0%) | - |
| Dec 2012 | - | $8.01M |
| Dec 2011 | $0.00 | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of AMPH is $74.65M
What is the all time high annual long term liabilities for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual total long term liabilities is $648.08M
What is Amphastar Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, AMPH annual total long term liabilities has changed by -$573.43M (-88.48%)
What is Amphastar Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of AMPH is $681.44M
What is the all time high quarterly long term liabilities for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $681.44M
What is Amphastar Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, AMPH quarterly total long term liabilities has changed by +$40.24M (+6.28%)